Does a non‑reactive hepatitis B surface antibody (anti‑HBs) indicate immunity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Non-Reactive Hepatitis B Surface Antibody Mean You Have Immunity?

No, a non-reactive (negative) hepatitis B surface antibody (anti-HBs) does NOT indicate immunity to hepatitis B virus. In fact, it indicates the opposite: you lack detectable antibody protection against HBV infection. 1

Understanding Anti-HBs and Immunity

A reactive (positive) anti-HBs result at levels ≥10 mIU/mL indicates immunity, not a non-reactive result. 1, 2 The presence of anti-HBs antibodies—whether from vaccination or recovery from natural infection—is what confers protection against HBV. 3

What Non-Reactive Anti-HBs Actually Means

  • Non-reactive anti-HBs indicates susceptibility to HBV infection and the need for vaccination (assuming you are not already infected). 1

  • Persons with non-reactive anti-HBs after completing a primary vaccine series should be revaccinated with a second complete series, followed by repeat testing 1–2 months after the final dose. 1

  • If anti-HBs remains non-reactive after revaccination, you should be tested for HBsAg to rule out chronic infection. 1

  • Individuals who remain anti-HBs negative after two complete vaccine series are considered non-responders (occurring in 5–32% of vaccinated persons) and should be counseled about their susceptibility to HBV. 1, 4

The Correct Interpretation of Immunity

Vaccine-Derived Immunity

  • Anti-HBs positive alone (without anti-HBc) indicates vaccine-derived immunity. 3

  • Antibody titers ≥10 mIU/mL against HBsAg are recognized as conferring protection against hepatitis B. 2

  • Persons who respond to hepatitis B vaccine have only anti-HBs present in their serology. 3

Natural Infection-Derived Immunity

  • Anti-HBs positive WITH anti-HBc positive indicates immunity from resolved natural infection. 3, 5

  • The majority of persons who recover from natural HBV infection will be positive for both anti-HBs and anti-HBc. 5

Critical Caveats About Anti-HBs Testing

False-Positive Scenarios

  • Anti-HBs can be detected for several months after hepatitis B immune globulin (HBIG) administration and does not represent true immunity. 3, 6

  • Passively acquired anti-HBs from blood product transfusions does not confer immunity and can lead to misinterpretation of immune status. 6

  • Recent transfusion recipients may have detectable anti-HBs that is passively acquired rather than actively produced, leaving them vulnerable to infection. 6

Waning Immunity Considerations

  • Among children who initially respond to vaccination with anti-HBs >10 mIU/mL, 15–50% have low or undetectable antibody concentrations 5–15 years after vaccination. 1

  • Despite declining anti-HBs to <10 mIU/mL, nearly all immunocompetent vaccinated persons remain protected through immune memory. 1, 7

  • Immune memory persists even when antibody levels become undetectable, with 67–76% of persons demonstrating an anamnestic response when given a booster dose years later. 1

Who Needs Ongoing Anti-HBs Monitoring

High-Risk Populations Requiring Periodic Testing

  • Healthcare workers and public safety workers at risk for blood or body fluid exposure should have anti-HBs testing upon hire or matriculation to ensure protective levels. 1, 3

  • Hemodialysis patients require annual anti-HBs screening because they may lose immunity over time and need booster doses when levels fall below 10 mIU/mL. 1, 5

  • Immunocompromised persons (HIV-infected, chemotherapy recipients, transplant patients) may need annual testing to assess anti-HBs concentrations. 1

  • Sex partners of HBsAg-positive persons should be tested to determine need for revaccination and other protective measures. 1

Management Algorithm for Non-Reactive Anti-HBs

If Never Vaccinated

  • Initiate a complete hepatitis B vaccine series immediately (3 doses at 0,1, and 6 months). 1

  • Test for anti-HBs 1–2 months after the final dose using a quantitative method that detects ≥10 mIU/mL. 1

If Previously Vaccinated

  • Administer a second complete vaccine series (all doses on an appropriate schedule). 1

  • Retest anti-HBs 1–2 months after the final dose of the second series. 1

  • If still non-reactive after two complete series, test for HBsAg to rule out chronic infection. 1

  • If HBsAg-negative, counsel the patient that they are a non-responder, remain susceptible to HBV, and require HBIG prophylaxis for any known exposure to HBV. 1

Common Pitfalls to Avoid

  • Do not confuse "non-reactive" with "immune"—these terms are opposite in meaning for anti-HBs testing. 1

  • Do not assume that a single negative anti-HBs result years after vaccination means vaccine failure; immune memory may persist despite undetectable antibodies in immunocompetent persons. 1, 7

  • Do not interpret anti-HBs positivity as immunity in patients who recently received HBIG or blood products without confirming vaccination history. 3, 6

  • Do not fail to test for HBsAg in persons who remain anti-HBs negative after two complete vaccine series, as they may have unrecognized chronic infection. 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Hepatitis B Surface Antibody Reactive: Immunity Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

5
Guideline

Interpretation of Hepatitis B Panel Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is a patient with a hepatitis B surface antibody (HBsAb) level less than 5 considered not immune to hepatitis B and in need of vaccination?
Does a reactive hepatitis B (HB) surface antibody indicate immunity to hepatitis B in a patient?
Does a patient with non-reactive hepatitis B (HB) surface antigen and non-reactive hepatitis B (HB) antibody, and no evidence of hepatitis B virus (HBV) infection, have immunity to hepatitis B?
What are the recommendations for a patient with non-reactive Hepatitis B (HBV) core antibody total and HBV surface antibody results, indicating a lack of immunity to Hepatitis B?
What is the appropriate next step for a patient who is seronegative for hepatitis B surface antibody (no immunity)?
In a 5-year-old child with persistent otitis media with effusion, conductive hearing loss noted by the teacher, and a retracted tympanic membrane, what is the most appropriate next step in management?
Can I add an SGLT2 inhibitor (e.g., dapagliflozin) to an adult with primary membranous nephropathy, sub-nephrotic proteinuria (~1 g/day), estimated glomerular filtration rate ≥30 mL/min/1.73 m², no recurrent genital or urinary tract infections, and no severe volume depletion or hypotension?
In a 39‑year‑old woman being evaluated after tubal reversal, should we order a day‑3 luteinizing hormone (LH) level now?
What is the most likely diagnosis and the appropriate dosing of co‑amoxiclav (amoxicillin/clavulanic acid) suspension 125 mg/5 mL and paracetamol for a 5‑year‑old girl weighing 27 kg with a 2‑day history of fever and a productive cough with green sputum?
In an adult patient with an ascending aortic aneurysm (≥5.5 cm, or ≥5.0 cm if bicuspid aortic valve or connective‑tissue disease) should the referral be to cardiothoracic (cardiac) surgery rather than vascular surgery?
What is the recommended management of severe hypertriglyceridemia in an adult with diabetic ketoacidosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question